| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| galcanezumab | calcitonin gene-related peptide 1 | biotech | NA | drugbank | Episodic Cluster Headache[MeSHID:D003027] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperprolactinemia[MeSHID:D006966] |
NA | approved,investigational | antibody |
| galcanezumab | calcitonin gene-related peptide 2 | biotech | NA | drugbank | Episodic Cluster Headache[MeSHID:D003027] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperprolactinemia[MeSHID:D006966] |
NA | approved,investigational | antibody |
| galcanezumab | calcitonin gene-related peptide receptor | NA | Successful target | TTD , DGIDB | Episodic Cluster Headache[MeSHID:D003027] Migraine Disorders[MeSHID:D008881] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Hyperprolactinemia[MeSHID:D006966] |
6.37 | approved | unknown |
| click here to return to the previous page | ||||||||